SEC Charges Kiromic BioPharma and Two Former C-Suite Executives with Misleading Investors about Status of FDA Reviews

Dec 3, 2024

The Securities and Exchange Commission today filed settled charges against Houston-based biotherapeutics company Kiromic BioPharma, Inc., its former CEO, Maurizio Chiriva-Internati, and its former chief financial officer, Tony Tontat, for failing to…

Full report at: Read More

More News

US Department of Labor seeks help of employees from Mar-Jac Poultry MS as investigation into young teen’s death at Hattiesburg plant continues

Attorney Mark Nicholson Secures Not Guilty Verdict in High-Stakes Trial

Fulgham Hampton Criminal Defense Attorneys Welcomes Gebhardt & Eppes in a Landmark Merger

SEC Proposes Revision to Privacy Act Rule

OSHA to hold public meeting June 15 to discuss modernizing, improving, expanding its Voluntary Protection Programs

Owner of Tennessee Mental Health Counseling Center Charged with Employment Tax Crimes

David M. Magann, P.A. Reports on VA’s Innovative Approach to PTSD with Psychedelic Research

FROM:

Peter Brill of Brill Legal Group Defends Former NYPD Police Chief Against Allegations

FROM:

Orange County Trust Litigation Attorney Blaine M. Brown Shares Expertise on Electronic Communications and Trust Amendments with the Daily Journal in his Article: Lines Drawn in Digital Ink

FROM:

Roberts & Roberts Law Firm Provides Free Rides to Prevent Drunk Driving This Holiday Season

FROM: